Techlott warned over sub-penny OTCQB share price
Techlott Inc. faces the risk of removal from the OTCQB Venture Market if it cannot lift its share price to required levels within a 90-day cure period.
Rhea-AI Filing Summary
Techlott Inc. (LOTT) reports that on July 28, 2026 it received a notice from OTC Markets Group that its common stock no longer meets the OTCQB Venture Market continued eligibility criteria because the closing bid price has been below $0.01 per share for more than 30 consecutive calendar days.
Under a 90-calendar-day cure period, the closing bid price must reach at least $0.01 per share for 10 consecutive trading days by October 26, 2026 to maintain OTCQB quotation. If the closing bid price is below $0.001 per share for five consecutive trading days, the common stock would be removed from the OTCQB Venture Market immediately, without any cure period.
Positive
- None.
Negative
- Risk of OTCQB removal: Techlott’s stock failed the OTCQB bid-price standard, triggering a 90-day cure period and creating a risk of delisting from the OTCQB Venture Market if price thresholds are not met.
8-K Event Classification
Key Figures
Key Terms
OTCQB Venture Market market
closing bid price financial
continued eligibility criteria regulatory
cure period regulatory
trading days market
FAQ
What triggered Techlott Inc. (LOTT) to receive an OTCQB deficiency notice?
What cure period has Techlott Inc. (LOTT) been given by OTCQB?
What is the deadline for Techlott Inc. (LOTT) to regain OTCQB compliance?
What happens if Techlott Inc. (LOTT) does not meet the OTCQB cure requirement?
Under what condition could Techlott Inc. (LOTT) be removed from OTCQB immediately?
On which market is Techlott Inc. (LOTT) currently quoted according to this report?
AI-generated analysis. How Rhea-AI works. Not financial advice.